Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/CME/Exam.aspx?id=4294983962

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294992027

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294992902

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294992903

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294992880

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294992879

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294992914

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294992913

Question 1

10/16/2019

Ms. Smith is a 32 yo woman with a past medical history significant for opioid use disorder and hepatitis C who presents for evaluation. She has had prior episodes of recovery and feels she has benefited from use of naltrexone IM injections. She has, however, relapsed many times and after her most recent relapse she

/Templates/Article.aspx?id=4294992892

Question 2

10/16/2019

Mr. Scott is a 47 yo gentleman you are treating for opioid use disorder with buprenorphine. Recently he has had a number of difficult life circumstances including a divorce, a demotion at work, and worsening of his chronic back pain. His last few toxicologies have shown some fentanyl and oxycodone, which are not

/Templates/Article.aspx?id=4294992893